期刊文献+
共找到200篇文章
< 1 2 10 >
每页显示 20 50 100
New method of local adjuvant therapy with bicarbonate Ringer’s solution for tumoral calcinosis: A case report
1
作者 Takashi Noguchi Akio Sakamoto +1 位作者 Kensaku Kakehi Shuichi Matsuda 《World Journal of Orthopedics》 2024年第3期302-309,共8页
BACKGROUND Tumoral calcinosis is a condition characterized by deposits of calcium phosphate crystals in extra-articular soft tissues,occurring in hemodialysis patients.Calcium phosphate crystals are mainly composed of... BACKGROUND Tumoral calcinosis is a condition characterized by deposits of calcium phosphate crystals in extra-articular soft tissues,occurring in hemodialysis patients.Calcium phosphate crystals are mainly composed of hydroxyapatite,which is highly infilt-rative to tissues,thus making complete resection difficult.An adjuvant method to remove or resolve the residual crystals during the operation is necessary.CASE SUMMARY A bicarbonate Ringer’s solution with bicarbonate ions(28 mEq/L)was used as the adjuvant.After resecting calcium phosphate deposits of tumoral calcinosis as much as possible,while filling with the solution,residual calcium phosphate deposits at the pseudocyst wall can be gently scraped by fingers or gauze in the operative field.A 49-year-old female undergoing hemodialysis for 15 years had swelling with calcium deposition for 2 years in the shoulders,bilateral hip joints,and the right foot.A shoulder lesion was resected,but the calcification remained and early re-deposition was observed.Considering the difficulty of a complete rection,we devised a bicarbonate dissolution method and excised the foot lesion.After resection of the calcified material,the residual calcified material was washed away with bicarbonate Ringer’s solution.CONCLUSION The bicarbonate dissolution method is a new,simple,and effective treatment for tumoral calcinosis in hemodialysis patients. 展开更多
关键词 Tumoral calcinosis Adjuvant therapy BICARBONATE ringers solution sURGERY Case report
下载PDF
Fluid resuscitation in acute pancreatitis: Normal saline or lactated Ringer's solution? 被引量:22
2
作者 Michal Lipinski Alicja Rydzewska-Rosolowska +1 位作者 Andrzej Rydzewski Grazyna Rydzewska 《World Journal of Gastroenterology》 SCIE CAS 2015年第31期9367-9372,共6页
AIM: To investigate whether administration of Ringer's solution(RL) could have an impact on the outcome of acute pancreatitis(AP).METHODS: We conducted a retrospective study on 103 patients [68 men and 35 women,me... AIM: To investigate whether administration of Ringer's solution(RL) could have an impact on the outcome of acute pancreatitis(AP).METHODS: We conducted a retrospective study on 103 patients [68 men and 35 women,mean age 51.2 years(range,19-92 years)] hospitalized between 2011 and 2012. All patients admitted to the Department of Gastroenterology of the Central Clinical Hospital of the Ministry of Interior(Poland) with a diagnosis of AP who had disease onset within 48 h of presentation were included in this study. Based on the presence of persistent organ failure(longer than 48 h) as a criterion for the diagnosis of severe AP(SAP) and the presence of local complications [diagnosis of moderately severe AP(MSAP)],patients were classified into 3 groups: mild AP(MAP),MSAP and SAP. Data were compared between the groups in terms of severity(using the revised Atlanta criteria) and outcome. Patients were stratified into 2 groups based on the type of fluid resuscitation: the 1-RL group who underwent standard fluid resuscitation with a RL 1000 m L solution or the 2-NS group who underwent standard fluid resuscitation with 1000 m L normal saline(NS). All patients from both groups received an additional 5% glucose solution(1000-1500 m L) and a multi-electrolyte solution(500-1000 m L).RESULTS: We observed 64(62.1%) patients with MAP,26(25.24%) patients with MSAP and 13(12.62%) patients with SAP. No significant difference in the distribution of AP severity between the two groups was found. In the 1-RL group,we identified 22(55.5%) MAP,10(25.5%) MSAP and 8(20.0%) SAP patients,compared with 42(66.7%) MAP,16(24.4%) MSAP and 5(7.9%) SAP cases in the 2-NS group(P = 0.187). The volumes of fluid administered during the initial 72-h period of hospitalization were similar among the patients from both the 1-RL and 2-NS groups(mean 3400 m L vs 3000 m L,respectively). No significant differences between the 1-RL and 2-NS groups were found in confirmed pancreatic necrosis [10 patients(25%) vs 12 patients(19%),respectively,P = 0.637]. There were no statistically significant differences between the 1-RL and 2-NS groups in the percentage of patients who required enteral nutrition(23 patients vs 17 patients,respectively,P = 0.534). Logistic regression analysis confirmed these findings(OR = 1.344,95%CI: 0.595-3.035,P = 0.477). There were no significant differences between the 1-RL and 2-NS groups in mortality and the duration of hospital stay(median of 9 d for both groups,P = 0.776).CONCLUSION: Our study failed to find any evidence that the administration of RL in the first days of AP leads to improved clinical outcomes. 展开更多
关键词 ACUTE PANCREATITIs Fuid THERAPY lactated ringers
下载PDF
Dynamics of vascular volume and hemodilution of lactated Ringer’s solution in patients during induction of general and epidural anesthesia 被引量:4
3
作者 LI Yu-hong LOU Xian-feng BAO Fang-ping 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2006年第9期738-744,共7页
Objective: To investigate the dynamics of vascular volume and the plasma dilution of lactated Ringer's solution in patients during the induction of general and epidural anesthesia. Methods: The hemodilution of i.v.... Objective: To investigate the dynamics of vascular volume and the plasma dilution of lactated Ringer's solution in patients during the induction of general and epidural anesthesia. Methods: The hemodilution of i.v. infusion of 1000 ml of lactated Ringer's solution over 60 min was studied in patients undergoing general (n=31) and epidural (n= 22) anesthesia. Heart rate, arterial blood pressure and hemoglobin (Hb) concentration were measured every 5 rain during the study. Surgery was not started until the study period had been completed. Results: General anesthesia caused the greater decrease of mean arterial blood pressure (MAP) (mean 15% versus 9%; P〈0.01) and thereby followed by a more pronounced plasma dilution, blood volume expansion (VE) and blood volume expansion efficiency (VEE). A strong linear correlation between hemodilution and the reduction in MAP (r=-0.50;P〈0.01) was found. At the end of infusion, patients undergoing general anesthesia retained 47% (SD 19%) of the infused fluid in the circulation, while epidural anesthesia retained 29% (SD 13%) (P〈0.001). Correspondingly, a fewer urine output (mean 89 ml versus 156 ml; P〈0.05) and extravascular expansion (454 ml versus 551 ml; P〈0.05) were found during general anesthesia. Conclusion: We concluded that the induction of general anesthesia caused more hemodilution, volume expansion and volume expansion efficiency than epidural anesthesia, which was triggered only by the lower MAP. 展开更多
关键词 HEMODILUTION Volume expansion ringer's solution General anesthesia Epidural anesthesia
下载PDF
Does Ringer Lactate Used in Parkland Formula for Burn Resuscitation Adequately Restore Body Electrolytes and Proteins?
4
作者 Medhat E. Habib Loai M. Saadah +4 位作者 Mazen Al-Samerrae Fathy E. Shoeib Mahaba Mamoun Gehan A. Latif Dalia M. Habib 《Modern Plastic Surgery》 2017年第1期1-12,共12页
Objective: Evaluation of the effect of Ringer Lactate, as the resuscitative burn fluid according to Parkland Formula, on restoring the levels of body electrolytes and proteins. Design: A retrospective cohort study. Se... Objective: Evaluation of the effect of Ringer Lactate, as the resuscitative burn fluid according to Parkland Formula, on restoring the levels of body electrolytes and proteins. Design: A retrospective cohort study. Setting: The National Burns Unit, Mafraq Hospital, Abu Dhabi, United Arab Emirates (UAE). Patients: One hundred and fifteen patients admitted with fresh burns between 1st of January 2011 and 31st of December 2013, who met inclusion and exclusion criteria. Methods: Team collected demographic and clinical data for each patient using a standard form. Patients received Ringer Lactate solely as the resuscitative burn fluid according to Parkland Formula. Baseline (pre-) and third-day (post-) variables included levels of sodium, potassium, chloride, proteins, and albumin. Researchers then performed paired comparisons of serum electrolytes and protein levels. Results: Mean values showed maintenance of the potassium and chloride levels within the normal range after administering the Ringer Lactate, significant decline in sodium, and a marked hypoproteinaemia and hypoalbuminaemia post-resuscitation. Conclusions: Ringer Lactate used as the mere resuscitative post burn fluid is suboptimal. Sodium supplementation may be required to correct hyponatremia. Colloids, preferably intravenous albumin should be added, as advised by the original Parkland Formula. 展开更多
关键词 ringer lactatE BURN Parkland Electrolytes PROTEINs
下载PDF
乳酸配合物(NH_(4))_(2)[Sr(C3H_(5)O_(3))_(4)]的晶体结构、Hirshfeld表面分析和溶液化学性质
5
作者 柯曾波 范新会 +4 位作者 邸友莹 陈凤英 张丽君 杨珂 李炳 《无机化学学报》 SCIE CAS CSCD 北大核心 2023年第3期521-532,共12页
合成了无水乳酸配合物(NH_(4))_(2)[Sr(C3H_(5)O_(3))4]。用X射线单晶衍射仪对该配合物的晶体结构进行了表征,确定了其组成、空间结构和配位方式。绘制了配合物的Hirshfeld表面和2D指纹图,揭示了分子间的相互作用以及该配合物具有多个... 合成了无水乳酸配合物(NH_(4))_(2)[Sr(C3H_(5)O_(3))4]。用X射线单晶衍射仪对该配合物的晶体结构进行了表征,确定了其组成、空间结构和配位方式。绘制了配合物的Hirshfeld表面和2D指纹图,揭示了分子间的相互作用以及该配合物具有多个配位位点和较强的配位活性。根据相关的晶体数据计算出了该配合物的晶格能及其对应阴离子的摩尔体积,计算得到该配合物的晶格能为2742.9 kJ·mol^(-1)。用等温环境反应-溶解量热计测量了该配合物在298 K超纯水溶剂中的溶解焓。根据Pitzer电解质溶液理论,在298 K下获得了该配合物的无限稀释摩尔溶解焓Δs H∞m和Pitzer参数,确定该配合物的Δs H∞m为(114.01±0.04)kJ·mol^(-1)。计算了该配合物的表观相对摩尔焓(ΦL)以及不同浓度下溶质和溶剂的相对偏摩尔焓(■和■)。最后,根据晶格能和Δs H∞m设计了热化学循环,并计算出了阴离子的水合焓值。热重和微商热重曲线进一步揭示了该配合物的结构。 展开更多
关键词 无水乳酸配合物 Hirshfeld表面分析 溶解焓 PITZER参数 晶格势能 水合焓
下载PDF
酵母静息细胞催化丙酮酸乙酯不对称还原制(S)-乳酸乙酯 被引量:8
6
作者 王丹 张强 +4 位作者 李旺 戚南昌 郭春晓 杨志荣 张杰 《催化学报》 SCIE EI CAS CSCD 北大核心 2011年第6期1035-1039,共5页
从污水处理池及其附近土壤中分离到36株可将丙酮酸乙酯不对称还原成(S)-乳酸乙酯的菌株,经多次复筛,最终得到一株具有较高催化活性的酵母菌BTY18-6.以BTY18-6的静息细胞为催化剂,在水相中进行丙酮酸乙酯不对称还原成(S)-乳酸乙酯的反应... 从污水处理池及其附近土壤中分离到36株可将丙酮酸乙酯不对称还原成(S)-乳酸乙酯的菌株,经多次复筛,最终得到一株具有较高催化活性的酵母菌BTY18-6.以BTY18-6的静息细胞为催化剂,在水相中进行丙酮酸乙酯不对称还原成(S)-乳酸乙酯的反应,并对反应条件进行了优化.结果表明,以2.5%葡萄糖为辅助底物,反应体系初始pH=6.8,发酵培养48h的菌体湿度0.175g/ml,丙酮酸乙酯初始浓度65mmol/L,于32oC反应48h的条件下,丙酮酸乙酯转化率达95.5%,产物对映体过量值(ee值)为92.1%. 展开更多
关键词 酵母静息细胞 生物催化 丙酮酸乙酯 不对称还原 (s)-乳酸乙酯
下载PDF
碳酸氢钠林格液与复方氯化钠注射液治疗脓毒性休克的效果比较 被引量:2
7
作者 郭卫东 高尚兰 姚童翔 《郑州大学学报(医学版)》 CAS 北大核心 2024年第1期87-91,共5页
目的:比较碳酸氢钠林格液、复方氯化钠注射液用于脓毒性休克的治疗效果。方法:选取2019年4月至2022年4月新乡市中心医院收治的脓毒性休克患者80例,分为A、B组,每组40例。A组接受碳酸氢钠林格液注射液限制性液体复苏,B组接受复方氯化钠... 目的:比较碳酸氢钠林格液、复方氯化钠注射液用于脓毒性休克的治疗效果。方法:选取2019年4月至2022年4月新乡市中心医院收治的脓毒性休克患者80例,分为A、B组,每组40例。A组接受碳酸氢钠林格液注射液限制性液体复苏,B组接受复方氯化钠注射液限制性液体复苏。比较两组患者复苏处理后0、1、3、6、12、24、48 h乳酸清除率,复苏第0、6、12、24、48 h电解质指标(K^(+)、Na^(+)、Cl^(-)),血流动力学恢复稳定时间(中心静脉压恢复时间、平均动脉压恢复时间),ICU住院时间,死亡率以及0、6、12、24、48 h快速序贯器官衰竭评分(qSoFA评分),48 h内所用液体总量,不良事件发生率。结果:0~48 h,两组乳酸清除率均呈升高趋势,A组高于B组(P<0.05)。两组不同时间点K^(+)、Na^(+)水平差异无统计学意义(P>0.05),Cl^(-)水平有随时间升高的趋势,且A组12、24、48 h Cl^(-)水平低于B组(P<0.05)。与B组相比,A组中心静脉压恢复时间、平均动脉压恢复时间、ICU住院时间更短,死亡率更低(P<0.05)。qSoFA评分有随时间降低的趋势,且A组12、24、48 h qSoFA评分低于B组(P<0.05)。A组48 h内所用液体总量少于B组(P<0.05)。两组不良事件发生率差异无统计学意义(P=0.644)。结论:碳酸氢钠林格液限制性液体复苏治疗脓毒性休克效果更好。 展开更多
关键词 碳酸氢钠林格液 复方氯化钠注射液 脓毒性休克 液体复苏
下载PDF
不同输血输液方案对失血性休克大鼠肾功能及AQP2,BSC1的影响 被引量:1
8
作者 李凯 高凤 +2 位作者 冷亚书 赵国庆 李龙云 《中国实验诊断学》 2014年第8期1222-1225,共4页
目的利用重度失血性休克大鼠模型,探讨不同输血输液方案对肾脏病理、肾功能、水通道蛋白-2(aquaporins-2water channel,AQP2),Na+-2Cl--K+协同转运蛋白-1(Na+-2Cl--K+co-transporter-1,BSC1)影响的差异及相关机制。方法 24只鼠随机分为C... 目的利用重度失血性休克大鼠模型,探讨不同输血输液方案对肾脏病理、肾功能、水通道蛋白-2(aquaporins-2water channel,AQP2),Na+-2Cl--K+协同转运蛋白-1(Na+-2Cl--K+co-transporter-1,BSC1)影响的差异及相关机制。方法 24只鼠随机分为C组(对照组)、LR组(血液与乳酸钠林格按1∶2稀释后,回输2/3)和HES组(血液与羟乙基淀粉按1∶2稀释后,回输2/3),每组8只,C组仅行股动静脉插管,其余两组经股动脉放血35%,使平均动脉压低于40mmHg达60min,建立大鼠急性失血性休克模型后,按方案输血输液后,缝合苏醒。24h后再次麻醉取材观察肾组织的病理学变化,并测定血清中肌酐(Cr)和尿素氮(BUN)含量,采集并记录尿量,检测尿比重,采用免疫组织化学及Western blot法分别对肾组织AQP2、BSC1进行定性和定量分析。结果与C组比较:1两组尿量增加,尿比重降低,组间无明显差异。2两组血清BUN、Cr水平均显著增加,两组间无差异。3两组肾组织病理损伤分级显著升高,两组间无差异。4Western blot及免疫组织化学结果显示,两组BSC1、AQP2蛋白表达表达均下调,HES组表达高于LR组。结论急性重度失血性休克能够引起肾脏损伤,与BSC1,AQP2蛋白的下调相关。血液与羟乙基淀粉1∶2混合输注的方案,对肾脏的保护作用优于血液与林格液方案,并可显著降低BSC1,AQP2蛋白的改变。 展开更多
关键词 失血性休克 羟乙基淀粉 乳酸钠林格注射液 BsC1 AQP2
下载PDF
生物可降解螯合剂[S,S]-乙二胺二琥珀酸和乳酸乙酯提取土壤中重金属的研究 被引量:4
9
作者 罗璐瑕 胡忻 《环境污染与防治》 CAS CSCD 北大核心 2007年第9期661-663,667,共4页
研究了生物可降解的有机螯合剂[S,S]-乙二胺二琥珀酸([S,S]-EDDS,简写为EDDS)和乳酸乙酯(EL)对重金属污染土壤中重金属的提取效率,并用X射线衍射(XRD)和红外光谱(FT-IR)分析了螯合剂提取对土壤理化性质的影响。结果表明:EDDS对土壤中的C... 研究了生物可降解的有机螯合剂[S,S]-乙二胺二琥珀酸([S,S]-EDDS,简写为EDDS)和乳酸乙酯(EL)对重金属污染土壤中重金属的提取效率,并用X射线衍射(XRD)和红外光谱(FT-IR)分析了螯合剂提取对土壤理化性质的影响。结果表明:EDDS对土壤中的Cd、Cu、Pb和Zn有较高的提取率,效果比EL好;EDDS和EL混合提取的重金属提取率增加,但相比单独使用EDDS没有超过10%。FT-IR分析表明,提取前后FT-IR谱图中特征吸收频率没有显著改变,但强度有所改变。XRD分析表明,提取前后土壤晶格结构发生明显的变化,螯合剂提取改变了土壤微观结构。 展开更多
关键词 重金属 土壤 提取 [s s]-乙二胺二琥珀酸 乳酸乙酯
下载PDF
乳酸在阿尔茨海默病中的作用机制研究进展
10
作者 郝志华 孙跃峰 +1 位作者 李松哲 陈晶 《中国医药》 2024年第7期1096-1100,共5页
阿尔茨海默病(AD)是一种神经退行性疾病,目前还没有发现可抑制AD进展的确切治疗方法。在对AD的研究中发现,乳酸在AD病变过程中起着多种作用,它可以为神经元活动提供能量也可以通过信号通路影响神经活动,协调不同细胞、器官和组织之间的... 阿尔茨海默病(AD)是一种神经退行性疾病,目前还没有发现可抑制AD进展的确切治疗方法。在对AD的研究中发现,乳酸在AD病变过程中起着多种作用,它可以为神经元活动提供能量也可以通过信号通路影响神经活动,协调不同细胞、器官和组织之间的信号传导,在学习记忆、神经发育和突触可塑性等多种生理病理过程中发挥调节作用。乳酸可以促进组蛋白赖氨酸进行乳酸化修饰,参与神经兴奋,炎症等重要过程。在此总结乳酸在AD中的多种作用机制和最新研究进展,以期为AD的防治和缓解提供新的视角。 展开更多
关键词 阿尔茨海默病 乳酸 炎症 乳酸化修饰
下载PDF
S-(—)-对甲苯磺酰乳酸甲酯的合成 被引量:6
11
作者 袁冠华 严成武 《化工时刊》 CAS 2004年第8期36-38,48,共4页
研究了以三乙胺为催化剂 ,二氯甲烷为溶剂 ,S- (— ) -乳酸甲酯和对甲苯磺酰氯发生酰化反应 ,合成S - (— )-对甲苯磺酰乳酸甲酯的方法 ,讨论了反应温度、时间、溶剂、催化剂和对甲苯磺酰氯对反应产率的影响。结果表明 :n(三乙胺 )∶n(S... 研究了以三乙胺为催化剂 ,二氯甲烷为溶剂 ,S- (— ) -乳酸甲酯和对甲苯磺酰氯发生酰化反应 ,合成S - (— )-对甲苯磺酰乳酸甲酯的方法 ,讨论了反应温度、时间、溶剂、催化剂和对甲苯磺酰氯对反应产率的影响。结果表明 :n(三乙胺 )∶n(S - (— ) -乳酸甲酯 ) =1∶1.2 ,0~ 5℃下 ,对甲苯磺酰氯的二氯甲烷溶液加入S - (— ) -乳酸甲酯中 ,得到S - (— ) -对甲苯磺酰乳酸甲酯。通过旋光度、熔点测定及IR分析 ,证实其结构与预期结构相符。收率为 95 % ,光学纯度 95 %。 展开更多
关键词 s-(—)-对甲苯磺酰乳酸甲酯 合成 三乙胺 二氯甲烷 s-(—)-乳酸甲酯 对甲苯磺酰氯 酰化反应 除草剂
下载PDF
谷胱甘肽S-转移酶和乳酸脱氢酶在亚洲带绦虫囊尾蚴中的表达 被引量:1
12
作者 方文 肖靓靓 +1 位作者 包怀恩 牟荣 《贵州农业科学》 CAS 北大核心 2011年第4期150-153,共4页
为开发相关疫苗和治疗靶分子,应用免疫组化、双向电泳(2-DE)结合蛋白质印迹(Western-blotting)技术对亚洲带绦虫囊尾蚴谷胱甘肽S-转移酶(GST)和乳酸脱氢酶(LDH)的表达进行了研究。结果表明:亚洲带绦虫囊尾蚴表达GST,囊尾蚴的... 为开发相关疫苗和治疗靶分子,应用免疫组化、双向电泳(2-DE)结合蛋白质印迹(Western-blotting)技术对亚洲带绦虫囊尾蚴谷胱甘肽S-转移酶(GST)和乳酸脱氢酶(LDH)的表达进行了研究。结果表明:亚洲带绦虫囊尾蚴表达GST,囊尾蚴的双向电泳凝胶共检测到204±11个蛋白质斑点,相对分子质量为Mr14 400~94 000,等电点(pI)为3.0~10.0;Western-blotting分析显示,GST和LDH特异性抗原抗体阳性杂交斑点均为1个,阴性对照均未见阳性杂交斑点;将Western-blotting检测的抗原抗体阳性杂交斑点与原双向电泳凝胶斑点进行比对,均找到对应蛋白斑点,经ImageMaster 2D Platinum 6.0软件分析后初步确定,该蛋白斑点的pI/Mr分别为6.5/25 588和8.2/35 318,与亚洲带绦虫GST和LDH的pI/Mr理论推导值接近。亚洲带绦虫囊尾蚴表达GST和LDH。 展开更多
关键词 亚洲带绦虫 囊尾蚴 谷胱甘肽s-转移酶 乳酸脱氢酶 免疫组化 双向电泳 蛋白质印迹
下载PDF
阴离子交换色谱法同时测定乳酸钠林格注射液中乳酸钠和总氯含量
13
作者 徐浩 朱静 +1 位作者 戴冬艳 陈剑秋 《中国药业》 CAS 2024年第20期76-78,共3页
目的建立同时测定乳酸钠林格注射液中乳酸钠和总氯含量的阴离子交换色谱法。方法分析柱为Dionex IonPac^(TM)AS11-HC柱(250 mm×4 mm),保护柱为AS11-HC柱(50 mm×4 mm),淋洗液为10 mmol/L氢氧化钾溶液,流速为1.0 mL/min,检测器... 目的建立同时测定乳酸钠林格注射液中乳酸钠和总氯含量的阴离子交换色谱法。方法分析柱为Dionex IonPac^(TM)AS11-HC柱(250 mm×4 mm),保护柱为AS11-HC柱(50 mm×4 mm),淋洗液为10 mmol/L氢氧化钾溶液,流速为1.0 mL/min,检测器温度为35℃,柱温为30℃,电导检测器,抑制器抑制电流为25 mA,进样量为25μL。结果乳酸根离子、氯离子质量浓度分别在9.97~249.37μg/mL、15.27~381.70μg/mL范围内与峰面积线性关系良好(r=0.9997,1.0000,n=6);精密度、稳定性、重复性试验结果的RSD均小于2.0%;平均加样回收率分别为100.74%,100.48%,RSD分别为1.17%,1.53%(n=9)。结论所建立的方法操作简便,灵敏度高,稳定性好,结果准确,可用于测定乳酸钠林格注射液中乳酸钠和总氯的含量。 展开更多
关键词 阴离子交换色谱法 乳酸钠 总氯 乳酸钠林格注射液 含量测定
下载PDF
碳酸氢钠林格液和复方林格液在控制性低中心静脉压肝切除术中的应用效果比较
14
作者 米琰 白玉 +2 位作者 徐刚 李素芬 卢锡华 《新乡医学院学报》 CAS 2024年第5期438-442,共5页
目的探讨碳酸氢钠林格液和复方林格液对控制性低中心静脉压(CLCVP)肝切除术患者的酸碱平衡及肝肾功能的影响。方法选择2020年6月至2022年6月在郑州大学附属肿瘤医院行CLCVP肝切除术的60例原发性肝癌患者为研究对象,按随机数字表法将患... 目的探讨碳酸氢钠林格液和复方林格液对控制性低中心静脉压(CLCVP)肝切除术患者的酸碱平衡及肝肾功能的影响。方法选择2020年6月至2022年6月在郑州大学附属肿瘤医院行CLCVP肝切除术的60例原发性肝癌患者为研究对象,按随机数字表法将患者分为碳酸氢钠林格液组和复方林格液组,每组30例。在麻醉诱导后至肝实质离断前,碳酸氢钠林格液组患者输注碳酸氢钠林格液,复方林格液组患者输注复方林格液。分别于麻醉诱导前(T_(1))、手术开始时(T_(2))、术中2 h(T_(3))、术中4 h(T_(4))和手术结束时(T_(5)),使用血气分析仪检测2组患者的pH值、碱剩余(BE)、血乳酸(Lac)水平;分别于术前24 h和术后24 h使用全自动生化分析仪检测2组患者血清丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)、血尿素氮(BUN)及血肌酐(Scr)水平;比较2组患者体质量、手术时间、术中输液量、尿量、手术过程中酸碱平衡变化及手术前后肝肾功能变化。结果2组患者体质量、手术时间、术中输液量及尿量比较差异均无统计学意义(P>0.05)。T_(1)时,2组患者pH值、BE、Lac水平比较差异无统计学意义(P>0.05);与T_(1)时比较,复方林格液组患者T_(2)时pH值升高,T_(3)~T_(5)时均降低,T_(2)~T_(5)的BE及Lac水平均升高(P<0.05);与T_(1)时比较,碳酸氢钠林格液组患者T_(2)时pH值显著升高,T_(3)时显著下降,T_(2)、T_(3)时BE及Lac水平均显著升高(P<0.05),T_(4)、T_(5)时pH值、BE、Lac水平与T_(1)时比较差异均无统计学意义(P>0.05);T_(5)时碳酸氢钠林格液组患者pH值显著高于复方林格液组,BE及Lac水平显著低于复方林格液组(P<0.05)。术前24 h,2组患者ALT、AST、BUN及Scr水平比较差异无统计学意义(P>0.05);2组患者术后24 h与术前24 h时的ALT、AST、BUN及Scr水平比较差异无统计学意义(P>0.05);术后24 h,2组患者的ALT、AST、BUN及Scr水平比较差异无统计学意义(P>0.05)。结论在CLCVP肝切除术中,相较于复方林格液,碳酸氢钠林格液对机体内环境的影响更小,可有效维持机体酸碱平衡稳定,且2种晶体溶液的使用均未对患者肝肾功能产生明显影响。 展开更多
关键词 控制性低中心静脉压肝切除术 原发性肝癌 碳酸氢钠林格液 复方林格液 酸碱平衡 肝肾功能
下载PDF
(S)-2-苄氧基丙醛的合成及结构表征
15
作者 徐东超 曲敏杰 +3 位作者 姜殿平 李成斌 郭静 阮久勇 《化工进展》 EI CAS CSCD 北大核心 2012年第6期1318-1320,1324,共4页
(S)-2-苄氧基丙醛是有机合成及制药的重要中间体,本文以(S)-乳酸乙酯为原料,经四氢吡咯胺化、氯化苄醚化、红铝还原反应合成了(S)-2-苄氧基丙醛,考察了胺化的反应时间、反应温度和原料的摩尔比对反应收率的影响。结果表明:当胺化反应时... (S)-2-苄氧基丙醛是有机合成及制药的重要中间体,本文以(S)-乳酸乙酯为原料,经四氢吡咯胺化、氯化苄醚化、红铝还原反应合成了(S)-2-苄氧基丙醛,考察了胺化的反应时间、反应温度和原料的摩尔比对反应收率的影响。结果表明:当胺化反应时间为75 h,最佳的反应温度为25℃,四氢吡咯与(S)-乳酸乙酯的摩尔比为1.4∶1时,胺化反应收率为94%,三步总收率为61.8%,采用GC-MS、IR、1H NMR表征确定了产物结构,研究结果为(S)-2-苄氧基丙醛的工业化生产奠定了基础。 展开更多
关键词 (s)-乳酸乙酯 胺化反应 (s)-2-苄氧基丙醛 合成
下载PDF
碳酸氢钠林格液与复方氯化钠注射液治疗脓毒性休克的疗效分析
16
作者 韦方莹 王思媛 于秋雨 《系统医学》 2024年第15期70-73,共4页
目的 探究碳酸氢钠林格液、复方氯化钠注射液应用于脓毒性休克患者中的治疗效果。方法 回顾性选取2021年8月—2023年10月江苏省连云港市赣榆区人民医院接受限制性液体复苏治疗脓毒性休克患者70例的临床资料,按治疗方法分组,对比对照组(n... 目的 探究碳酸氢钠林格液、复方氯化钠注射液应用于脓毒性休克患者中的治疗效果。方法 回顾性选取2021年8月—2023年10月江苏省连云港市赣榆区人民医院接受限制性液体复苏治疗脓毒性休克患者70例的临床资料,按治疗方法分组,对比对照组(n=35,复方氯化钠注射液)与观察组(n=35,碳酸氢钠林格液)在乳酸清除情况、电解质平衡状态上的差异。结果 观察组用药后1、3、6 h乳酸测量值均较对照组低,差异有统计学意义(P均<0.05)。治疗后48 h观察组Cl-水平(106.23±3.17)mmol/L低于对照组(110.94±2.72)mmol/L,差异有统计学意义(t=6.671,P<0.05)。结论 在脓毒性休克的限制性液体复苏治疗之中,推荐选择碳酸氢钠林格液,相比复方氯化钠注射液可有效清除体内乳酸、维持水电解质平衡、预防功能衰竭,促使患者快速康复。 展开更多
关键词 碳酸氢钠林格液 复方氯化钠注射液 脓毒性休克 治疗效果
下载PDF
6%羟乙基淀粉对CSEA患者围术期液体治疗的有效性和安全性评价
17
作者 王建慧 《中国现代医生》 2009年第1期20-21,共2页
目的评价6%羟乙基淀粉(6%HES,200/0.5)预扩容的有效性和安全性。方法60例择期手术患者(ASAΙ~Ⅱ级,年龄20~60岁)随机分为6%HES组(H组)和复方乳酸钠组(R组),每组各30例,所有患者均采用CSEA。麻醉前30min以15mL(/kg.h)的速度输入6%HES... 目的评价6%羟乙基淀粉(6%HES,200/0.5)预扩容的有效性和安全性。方法60例择期手术患者(ASAΙ~Ⅱ级,年龄20~60岁)随机分为6%HES组(H组)和复方乳酸钠组(R组),每组各30例,所有患者均采用CSEA。麻醉前30min以15mL(/kg.h)的速度输入6%HES或复方乳酸钠溶液,输液1h后以50mL/h的滴速维持滴注。术中连续监测平均动脉压、心率、脉搏血氧饱和度,并于各时间点行动脉血气、酸碱平衡和电解质分析。结果扩容后R组MAP、HR和SpO2无明显改变,H组MAP明显上升。两组PH、HCO-3、BE于扩容后轻度下降(P<0.05),血浆Na+、K+、Ca2+无显著性差异,H组扩容后Hct、Hb下降,且H组比R组明显(P<0.05)。结论6%HES作为容量替代治疗用品是安全有效的,但是输入6%HES后可导致轻度的代谢性酸中毒,应予重视。 展开更多
关键词 羟乙基淀粉 复方乳酸钠 预扩容 代谢性酸中毒
下载PDF
Plasma-Lyte 148: A clinical review 被引量:5
18
作者 Laurence Weinberg Neil Collins +2 位作者 Kiara Van Mourik Chong Tan Rinaldo Bellomo 《World Journal of Critical Care Medicine》 2016年第4期235-250,共16页
AIM To outline the physiochemical properties and specific clinical uses of Plasma-Lyte 148 as choice of solution for fluid intervention in critical illness, surgery and perioperative medicine.METHODS We performed an e... AIM To outline the physiochemical properties and specific clinical uses of Plasma-Lyte 148 as choice of solution for fluid intervention in critical illness, surgery and perioperative medicine.METHODS We performed an electronic literature search from Medline and Pub Med(via Ovid), anesthesia and pharmacology textbooks, and online sources including studies that compared Plasma-Lyte 148 to other crystalloid solutions. The following keywords were used: "surgery", "anaesthesia", "anesthesia", "anesthesiology", "anaesthesiology", "fluids", "fluid therapy", "crystalloid", "saline", "plasma-Lyte", "plasmalyte", "hartmann's", "ringers" "acetate", "gluconate", "malate", "lactate". All relevant articles were accessed in full. We summarized the data and reported the data in tables and text. RESULTS We retrieved 104 articles relevant to the choice of Plasma-Lyte 148 for fluid intervention in critical illness, surgery and perioperative medicine. We analyzed the data and reported the results in tables and text.CONCLUSION Plasma-Lyte 148 is an isotonic, buffered intravenous crystalloid solution with a physiochemical composition that closely reflects human plasma. Emerging data supports the use of buffered crystalloid solutions in preference to saline in improving physicochemical outcomes. Further large randomized controlled trials assessing the comparative effectiveness of PlasmaLyte 148 and other crystalloid solutions in measuring clinically important outcomes such as morbidity and mortality are needed. 展开更多
关键词 surgery Anesthesia Fluid therapy CRYsTALLOIDs sALINE Plasma-Lyte Hartmann’s ringers ACETATE GLUCONATE lactatE
下载PDF
Preparation,characterization and catalytic properties of S_2O_8^(2-)/ZrO_2-CeO_2 solid superacid catalyst 被引量:25
19
作者 樊国栋 沈茂 +1 位作者 张昭 贾发瑞 《Journal of Rare Earths》 SCIE EI CAS CSCD 2009年第3期437-442,共6页
A novel solid superacid catalyst S2O8^2-/ZrO2-CeO2 was prepared by a coprecipitation method and characterized by means of XRD FTIR, BET, TEM and DSC/TG analysis methods. The results indicated that incorporation of app... A novel solid superacid catalyst S2O8^2-/ZrO2-CeO2 was prepared by a coprecipitation method and characterized by means of XRD FTIR, BET, TEM and DSC/TG analysis methods. The results indicated that incorporation of appropriate amounts of Ce into the catalyst was beneficial to the formation of sole tetragonal ZrO2 and effectively prevented from the formation of monoclinic ZrO〉 and restrained the loss of sulfated species. XRD revealed the presence of tetragonal Ce0.16Zr0.84O2phase in the case of S2O8^2-/ZrO2-CeO2 calcined above 500 ℃. Catalytic activities of S2O8^2-/ZrO2-CeO2 for the esterification of lactic acid with n-butanol was studied. The results showed that the optimum conditions were as follows: calcination temperature of the catalyst 600 ℃, n(lactic acid):n(n-butyl alcohol)=1.0:3.0, w(S2O8^2-/ZrO2- CeO2)=12.0%, reaction temperature 145 ℃, and reaction time 2 h. The esterification efficiency of lactic acid was about 96.6%. 展开更多
关键词 solid superacid catalyst s2O8^2-/ZrO2-CeO2 n-butyl lactate EsTERIFICATION rare earths
下载PDF
Pyruvate-fortified resuscitation stabilizes cardiac electrical activity and energy metabolism during hypovolemia 被引量:3
20
作者 Hunaid A Gurji Daniel W White +3 位作者 Besim Hoxha Jie Sun Albert H Olivencia-Yurvati Robert T Mallet 《World Journal of Critical Care Medicine》 2013年第4期56-64,共9页
AIM: To test the hypothesis that fluid resuscitation with Ringer's solution enriched with pyruvate(PR), a physiological antioxidant and energy substrate, affords protection of myocardial metabolism and electrophys... AIM: To test the hypothesis that fluid resuscitation with Ringer's solution enriched with pyruvate(PR), a physiological antioxidant and energy substrate, affords protection of myocardial metabolism and electrophysiological performance superior to lactated Ringer's(LR) during hypovolemia and hindlimb ischemia-reperfusion.METHODS: Male domestic goats(25-30 kg) were exsanguinated to a mean arterial pressure of 48 ± 1 mm Hg. Right hindlimb ischemia was imposed for 90 min by applying a tourniquet and femoral crossclamp. LR or PR, infused iv, delivered 0.05 mmol/kg per minute L-lactate or pyruvate, respectively, from 30 min hindlimb ischemia until 30 min post-ischemia. Time controls(TC) underwent neither hemorrhage, hindlimb ischemia nor resuscitation. Goats were sacrificed and left ventricular myocardium biopsied at 90 min fluid resuscitation(n = 6 per group) or 3.5 h later(n = 9 LR, 10 PR, 8 TC).RESULTS: Myocardial 8-isoprostane content, phosphocreatine phosphorylation potential, creatine kinase activity, and heart rate-adjusted QT interval(QTc) vari- ability were evaluated at 90 min resuscitation and 3.5 h post-resuscitation. PR sharply lowered pro-arrhythmic QTc variability vs LR(P < 0.05); this effect persisted 3.5 h post-resuscitation. PR lowered myocardial 8-isoprostane content, a product of oxidative stress, by 39 and 37% during and 3.5 h after resuscitation, respectively, vs LR. Creatine kinase activity fell 42% post-LR vs TC(P < 0.05), but was stable post-PR(P < 0.02 vs post-LR). PR doubled phosphocreatine phosphorylation potential, a measure of ATP free energy state, vs TC and LR(P < 0.05); this energetic enhancement persisted 3.5 h post-resuscitation.CONCLUSION: By augmenting myocardial energy state and protecting creatine kinase activity, pyruvateenriched resuscitation stabilized cardiac electrical function during central hypovolemia and hindlimb ischemiareperfusion. 展开更多
关键词 CREATINE kinase Electrocardiogram HYPOVOLEMIA 8-Isoprostane PHOsPHOCREATINE Reactive oxygen species ringers lactatE
下载PDF
上一页 1 2 10 下一页 到第
使用帮助 返回顶部